SCHEMBL21633596

SCHEMBL21633596

Cc1cc(C(=O)C2CCN(C(=O)OC(C)(C)C)CC2)c(F)cc1F

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
STS P08842 9/20 0.51
DPP4 P27487 1/20 0.49
PTPN2 P17706 1/20 0.47
PTPN1 P18031 1/20 0.47
PTPN6 P29350 1/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 1/20 0.46
CPS1 P31327 1/20 0.46
EPHX2 P34913 1/20 0.45
RECQL P46063 1/20 0.45
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
GPR119 Q8TDV5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15566264 0.83 MEN1 (0.54) STSDPP4PTPN2PTPN1PTPN6
SCHEMBL16818362 0.82 STS (0.57) STSDPP4PTPN2PTPN1PTPN6
SCHEMBL17495365 0.81 USP30 (0.50) STSDPP4PTPN2PTPN1PTPN6
SCHEMBL22491573 0.81 STS (0.56) STSPTPN2PTPN1PTPN6HPGD
SCHEMBL20971852 0.80 STS (0.56) STSPTPN2PTPN1PTPN6KMT2A
SCHEMBL17007796 0.80 GPR119 (0.56) STSDPP4PTPN2PTPN1PTPN6
SCHEMBL2960444 0.80 STS (0.56) STSDPP4PTPN2PTPN1PTPN6
SCHEMBL29039960 0.80 CPS1 (0.73) STSPTPN2PTPN1PTPN6KMT2A
SCHEMBL15566640 0.80 STS (0.54) STSPTPN2PTPN1PTPN6HPGD
SCHEMBL17086608 0.80 RECQL (0.46) STSDPP4PTPN2PTPN1PTPN6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078115-A1 ALIPHATIC ACID AMIDE DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2026-03-19 US disclosed
US-12503463-B2 Aliphatic acid amide derivative Sumitomo Pharma Co., Ltd. (JP) 2025-12-23 US disclosed
EP-4082616-B1 ALIPHATIC ACID AMIDE DERIVATIVE SUMITOMO PHARMA CO LTD (JP) 2025-09-03 EP disclosed
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2025-03-13 US disclosed
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity SUMITOMO PHARMA CO. LTD. (JP) 2024-12-31 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
EP-4082616-A1 ALIPHATIC ACID AMIDE DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2022-11-02 EP disclosed
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity Sumitomo Pharma Co., Ltd. (JP) 2022-10-11 US disclosed
CN-114981264-A Fatty acid amide derivatives 住友制药株式会社 2022-08-30 CN disclosed
WO-2021132311-A1 ALIPHATIC ACID AMIDE DERIVATIVE 大日本住友製薬株式会社 2021-07-01 WO disclosed
EP-3828182-A1 FUSED RING LACTAM DERIVATIVES Sumitomo Dainippon Pharma Co., Ltd. (JP) 2021-06-02 EP disclosed
CN-112424195-A Condensed lactam derivatives 大日本住友制药株式会社 2021-02-26 CN disclosed
US-10745401-B2 Condensed lactam derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-18 US disclosed
US-10745401-B2 Condensed lactam derivative SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-18 US disclosed
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-13 US disclosed
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-13 US disclosed
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-06-04 US disclosed
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-06-04 US disclosed
WO-2020022237-A1 FUSED RING LACTAM DERIVATIVES 大日本住友製薬株式会社 2020-01-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255432-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 STS 142/4885DPP4 1900/4885PTPN2 4819/4885
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 STS 135/4885DPP4 2252/4885PTPN2 3636/4885
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity HTR5A, HTR1A, TPH1 STS 591/4885DPP4 1731/4885PTPN2 2789/4885
US-10745401-B2 Condensed lactam derivative PSEN1, GRIN1, HDAC1 STS 142/4885DPP4 1900/4885PTPN2 4819/4885
US-11466007-B2 Substituted lactams showing serotonin 5-HT receptor activity HTR1A, HTR5A, TPH1 STS 135/4885DPP4 2252/4885PTPN2 3636/4885
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 STS 135/4885DPP4 2252/4885PTPN2 3636/4885
US-20200172543-A1 CONDENSED LACTAM DERIVATIVE PSEN1, GRIN1, HDAC1 STS 142/4885DPP4 1900/4885PTPN2 4819/4885
US-12503463-B2 Aliphatic acid amide derivative HTR2A, HTR1A, HTR7 STS 3012/4885DPP4 4131/4885PTPN2 2527/4885
US-20260078115-A1 ALIPHATIC ACID AMIDE DERIVATIVE HTR1D, HTR1A, HTR7 STS 1808/4885DPP4 2299/4885PTPN2 1649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.